Comparative Benchmarking
In the context of the broader market, OKYO competes directly with industry leaders such as MAIA and CSBR. With a market capitalization of $79.24M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against MAIA's N/A and CSBR's 46.65%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
